BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aldawsari HM, Singh S, Alhakamy NA, Bakhaidar RB, Halwani AA, Sreeharsha N, Badr-eldin SM. Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals 2022;15:544. [DOI: 10.3390/ph15050544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Wang M, Li Y, Xia H, Cheng Y, Liu C, Xia Y, Wang Y, Yue Y, Cheng X, Xie Z. The Fabrication of Docetaxel-Containing Emulsion for Drug Release Kinetics and Lipid Peroxidation. Pharmaceutics 2022;14:1993. [DOI: 10.3390/pharmaceutics14101993] [Reference Citation Analysis]
2 Chaudhari D, Katari O, Ghadi R, Kuche K, Date T, Bhargavi N, Jain S. Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes. ACS Biomater Sci Eng 2022. [PMID: 35896042 DOI: 10.1021/acsbiomaterials.2c00594] [Reference Citation Analysis]